FR2805824B1 - Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 - Google Patents
Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21Info
- Publication number
- FR2805824B1 FR2805824B1 FR0002795A FR0002795A FR2805824B1 FR 2805824 B1 FR2805824 B1 FR 2805824B1 FR 0002795 A FR0002795 A FR 0002795A FR 0002795 A FR0002795 A FR 0002795A FR 2805824 B1 FR2805824 B1 FR 2805824B1
- Authority
- FR
- France
- Prior art keywords
- trisomy
- cytotrophoblasts
- crops
- markers
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Developmental Biology & Embryology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pregnancy & Childbirth (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0002795A FR2805824B1 (fr) | 2000-03-03 | 2000-03-03 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
PCT/FR2001/000619 WO2001065264A1 (fr) | 2000-03-03 | 2001-03-02 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
US10/220,433 US20030138435A1 (en) | 2000-03-03 | 2001-03-02 | Trisomy 21 cytotrophoblast cultures,and uses thereof for obtaining trisomy 21 markers |
CA002401603A CA2401603A1 (fr) | 2000-03-03 | 2001-03-02 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
JP2001563908A JP2003525056A (ja) | 2000-03-03 | 2001-03-02 | トリソミー21の細胞栄養芽層培養物、及びトリソミー21マーカーを得るためのその使用 |
EP01913925A EP1259824A1 (fr) | 2000-03-03 | 2001-03-02 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0002795A FR2805824B1 (fr) | 2000-03-03 | 2000-03-03 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2805824A1 FR2805824A1 (fr) | 2001-09-07 |
FR2805824B1 true FR2805824B1 (fr) | 2002-05-03 |
Family
ID=8847721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0002795A Expired - Fee Related FR2805824B1 (fr) | 2000-03-03 | 2000-03-03 | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030138435A1 (fr) |
EP (1) | EP1259824A1 (fr) |
JP (1) | JP2003525056A (fr) |
CA (1) | CA2401603A1 (fr) |
FR (1) | FR2805824B1 (fr) |
WO (1) | WO2001065264A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI367260B (en) * | 2005-03-18 | 2012-07-01 | Univ Hong Kong Chinese | Method for detecting the presence of a fetus with trisomy 21 in a pregnant woman and kit thereof |
CN114167057B (zh) * | 2021-12-10 | 2024-04-19 | 大连医科大学 | 一种诊断流产的生物学标志物及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2894889A (en) * | 1988-02-01 | 1989-08-03 | Monoclonetics International Incorporated | Genetic markers for down's syndrome, fetal abnormalities and twins |
-
2000
- 2000-03-03 FR FR0002795A patent/FR2805824B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-02 EP EP01913925A patent/EP1259824A1/fr not_active Ceased
- 2001-03-02 CA CA002401603A patent/CA2401603A1/fr not_active Abandoned
- 2001-03-02 US US10/220,433 patent/US20030138435A1/en not_active Abandoned
- 2001-03-02 WO PCT/FR2001/000619 patent/WO2001065264A1/fr active Application Filing
- 2001-03-02 JP JP2001563908A patent/JP2003525056A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20030138435A1 (en) | 2003-07-24 |
CA2401603A1 (fr) | 2001-09-07 |
JP2003525056A (ja) | 2003-08-26 |
WO2001065264A1 (fr) | 2001-09-07 |
EP1259824A1 (fr) | 2002-11-27 |
FR2805824A1 (fr) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
DZ3347A1 (fr) | Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase | |
DE60044625D1 (de) | Système d'assistance de conduire pour vehicules | |
SG100740A1 (en) | Disposable pants of trunks-type | |
FR2864312B1 (fr) | Carte de manoeuvrabilite laterale pour mobile et son procede d'obtention | |
FR2809000B1 (fr) | Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution | |
FR2816843B1 (fr) | Inhibiteurs de l'enzyme 5 alpha-reductase | |
FR2805456B1 (fr) | Prothese totale de genou, du type dit "postero-stabilisee" | |
FR2805824B1 (fr) | Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 | |
FR2797442B1 (fr) | Derives acetamido de calixarenes, leur preparation et leur utilisation pour l'extraction du strontium | |
FR2822846B1 (fr) | Procede de preparation et de selection d'anticorps | |
ITFI20000145A0 (it) | Carrello "intelligente" per servizi commerciali | |
FR2833016B1 (fr) | Nouvelles biomasses bacteriennes, leur protocole d'obtention, et leur utilisation pour la bacterisation de sols et de residus de cultures | |
FR2829927B1 (fr) | Nouvelles compositions cosmetiques et leur procede d'obtention | |
AU3075202A (en) | Compositions and methods for the discovery and selection of biological information | |
FR2823747B1 (fr) | Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires | |
FR2823751B1 (fr) | Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires | |
FR2832149B1 (fr) | Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique | |
AU2001251462A1 (en) | Compositions and methods for detection of von willebrand's disease | |
FR2804112B1 (fr) | Procede d'obtention de cyclotrimeres d'isocyanate(s) ramifie(s) faiblement colore(s) et composition en decoulant | |
ITMI20000810A0 (it) | Procedimento per la preparazione di 5'-acetilstavudina | |
IL155526A0 (en) | Compositions and methods for the discovery and selection of biological information | |
FR2808528B1 (fr) | Procede d'obtention de polyisocyanate(s) ramifie(s) faiblement colore(s), et composition en decoulant | |
FR2792315B1 (fr) | Nouvelles benzodioxinones et leur procede d'obtention | |
FR2820135B1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20091130 |